Novartis Patient Support Program

GLEEVEC Reports: Patient Support Program

Enrollment Survey

If you are taking GLEEVEC (imatinib mesylate) tablets for your Philadelphia chromosome positive (Ph+) chronic myeloid leukemia (CML), you qualify to enroll in a free support program from Novartis Oncology called GLEEVEC Reports. GLEEVEC Reports has been designed specifically to help people with Ph+ CML. Once you enroll in the program you will receive the latest information about Ph+ CML as well as personalized materials that will tell you:

  • How Gleevec works
  • What to expect from treatment
  • How to manage your condition
  • How to find support
  • How to talk to your doctor

Click Here to Enroll


  SITE MAP
Home | maillist.asp | contact.asp | Photoalbumdb.asp | Calendar.asp
Gleevec | Novartis Patient Support Program | Gleevec - 100mg Users | Why Join My Mail List | Tumor Growth Learning Tool | Cancer News | FOX 5 News Report


You are visitor number 5619 to this page.
©2006 GIST, an Orphan Cancer and a Personal Story
All Rights Reserved.

Hosted by

Thorough Solutions, Inc.
Tell a Friend about this site: